Registration for ASGCT's 28th Annual Meeting is NOW OPEN! Join us May 13-17 in New Orleans for the premier event in CGT.
Browse and view ASGCT's patient and clinician-focused content on-demand. This resource is made available exclusively for ASGCT members.
ASGCT membership unlocks incredible discounts and on-demand access to a rich archive documenting the history of cell and gene therapy. Take the next step in your career by becoming an ASGCT member.
Join
December 2, 2020 This event is in partnership between ASGCT and the Brazilian Association of Cellular and Gene Therapy. The goal of this program is for speakers with experience in clinical development to share their experiences and insights on factors to consider to successfully initiate clinical trials of in vivo and ex vivo gene therapies in Brazil. 🔒
April 18, 2023 Speakers from China share their expertise in development of vaccines and gene therapies. 🔒
August 30, 2023 Learn from Australian researchers working on gene therapy for the liver, eye, and haematopoietic system. 🔒
March 27, 2024 Discover the latest breakthroughs in gene and cell therapy research through an exclusive webinar collaboration between the American Society of Gene and Cell Therapy and the Japanese Society of Gene and Cell Therapy, fostering international collaboration and knowledge exchange. 🔒
September 19, 2019 During each of these five webinars, hear from clinicians, patients, and others at various stages of receiving gene therapy treatments. 🔒
October 16, 2023 Dive deep into the latest research and discoveries from past Annual Meeting abstracts. 🔒
June 15-16, 2022 During this free two-day symposium, speakers from around the world shared their insights and experience in development of cell therapies in the Middle East. 🔒
January 25, 2022 Speakers give a general overview of the pathogenesis of COVID-19, describe clinical aspects of long COVID, address aberrant immune responses in patients with long COVID, and discuss how neurological damage caused by the virus may contribute to persisting symptoms. 🔒
October 9, 2021 During this free virtual symposium, attendees gain insights on how to successfully initiate trials of in vivo and ex vivo gene therapies in India. 🔒
June 5, 2024 Patients accessing cell and gene therapies (CGTs) can face barriers in development, eligibility, coverage, referrals, and logistics. ASGCT experts discuss approved products, eligibility criteria, CAR-T lessons, provider knowledge, and how CGTs excite families compared to current sickle cell care. 🔒
December 5, 2023 Listen to Quick Takes from experts Samuel Hughes, MBA; Jean Johnston, and Jodi Wolff, PhD. 🔒
October 19, 2022 In this session we explore use of gene therapy approaches to treat Pompe disease and discuss challenges as well as novel uses of AAV to treat neuromuscular disorders. 🔒
June 22, 2021 Key stakeholders in the space will present a variety of novel models for the development of gene therapy for people with ultra-rare diseases and those living in countries with lower income economies. 🔒
February 23, 2022 This session highlights the ongoing research related to the administration of high-dose adeno-associated virus (AAV) in patients with an emphasis on safety and tolerability findings. Speakers provide a better understanding of the responses of patients to systemic delivery of AAV and the array of related factors. 🔒
December 7, 2022 After decades of research, gene editing has made its way into the clinic - but technical and ethical challenges remain. Speakers during this session give attendees an overview of the development history of gene editing technologies and present some of the newest research in the field. 🔒
June 23, 2022 Members of the Patient Outreach Committee who were onsite at the meeting attended oral abstract sessions and prepared to report on any new and relevant findings. 🔒
July 28, 2022 Researchers break down the preclinical models for gene therapies and a patient advocate shares direct examples of how communities can gather this data to further expand the knowledge around their disease and possible treatments. 🔒
February 24, 2022 Experts in the field review different gene therapy approaches, disease applications, and research processes, and describe the current state of the field. 🔒
September 10, 2021 Clinicians share insights on gene therapy options for SMA and a parent discusses having a child receive approved treatments. 🔒
April 27, 2023 There are different kinds of vectors, or delivery methods, used in gene and cell therapy to get working genetic material to a cell. This session explores the use of non-viral vectors as a mechanism to deliver this material and give examples and reason for being used over traditional viral vectors. 🔒
March 31, 2022 During this event, experts in the field dive further into viral vectors, a common delivery approach used in gene therapy. 🔒
January 27, 2023 Join us as patients highlight their stories, from navigating the diagnosis process to learning about and receiving investigational treatment options. 🔒
October 27, 2022 Attendees will learn about how researchers work with patient organizations to help advance science around a particular disease or disorder, and how they interact with other stakeholders to further their findings. 🔒
November 17, 2022 A clinician and caregiver give their perspectives and advice on navigating the diagnosis process to considering a treatment plan related to gene therapy. 🔒
August 25, 2022 During this Lunch & Learn, we break down the most common routes of gene therapy drug delivery and review the preclinical study model and how these routes are currently used in certain approved therapies or clinical trials. 🔒
November 16, 2022 This session explores approaches and tools for achieving cell lineage specification through reprogramming, noting both progress and pitfalls. 🔒
September 16, 2022 Talking about our profession is not an easy thing to do with people outside of the lab. Join Grant Holley, PhD, for a Professional Development Café on how to better talk about and educate differing audiences on what you do and why you do it. 🔒
November 18, 2022 This session explores foundational cases in biomedical research (e.g., embryo culture, biobanking, translational research, CRISPR) that have shaped approaches to defining ethical limits and the forms of deliberation, participation, exclusion, and oversight they exemplify. 🔒
October 19, 2023 Explore cutting-edge prenatal cell and gene therapy tools and the ethics involved. 🔒
January 22-23, 2025 | Virtual
© 2000-2024 All rights reserved. American Society of Gene & Cell Therapy.
Kentico CMS Development by Reason One | Powered by Kentico